Skip to main content

Mathematical analysis of a within-host model of SARS-CoV-2


In this paper, we have mathematically analyzed a within-host model of SARS-CoV-2 which is used by Li et al. in the paper “The within-host viral kinetics of SARS-CoV-2” published in (Math. Biosci. Eng. 17(4):2853–2861, 2020). Important properties of the model, like nonnegativity of solutions and their boundedness, are established. Also, we have calculated the basic reproduction number which is an important parameter in the infection models. From stability analysis of the model, it is found that stability of the biologically feasible steady states are determined by the basic reproduction number \((\chi _{0})\). Numerical simulations are done in order to substantiate analytical results. A biological implication from this study is that a COVID-19 patient with less than one basic reproduction ratio can automatically recover from the infection.


A deadly virus, called SARS-CoV-2 and mostly known as coronavirus, has affected most of the countries from November 2019. The World Health Organization declared it as a pandemic, as the virus affected more than a hundred countries and killed lots of people worldwide, especially in Europe and the USA in a short period [1]. During this rampant situation, to stop the virus propagation, almost all the regions of the world have been locked-down by applying strict social distancing measures and banned social gathering in all circumstances. Research is going on all over the world to control this epidemic from different points of view, such as pathology [2, 3], microbiology [4, 5], mathematics [6, 7], and so on [810]. Until now, several mathematical models have been suggested to study the population dynamics of coronavirus [8], but few of them could predict the outcomes accurately.

As we know, mathematical studies demonstrate the best strategies for controlling any type of disease or virus infection in humans [11, 12]. The modeling of any disease helps to decide on public health and introduces the disease treatment. When the primary studies of any deadly disease cannot give us any concluding remarks to take significant decisions to control the pandemic situation, the key facts of mathematical modeling always help the human civilization. Mathematical models of viral dynamics with viral and antiviral drug effects are examined and assisted by their transparent structures and biologically feasible parameters. There is much work to be done now and in the future to assess the figure of confirmed cases of COVID-19. Also, a few studies focused on confirmed cases, risk history, and disease schedule characteristics [8, 12, 13]. Mathematical models of epidemiology have been developed to help policymakers in making the right decisions at the right time. These models highlight that isolation plays an important role in controlling the spread of the virus [6, 13]. But this is not a solution to the long-term vision as a country’s economic growth globally is declining due to the locked-downs to maintain social distancing [7]. Therefore, researchers and scientists are now developing dynamic viral within-host models to understand the mechanisms of SARS-CoV-2 in the human body. To date, only a few host-level models [4, 5] have been developed to understand the SARS-CoV-2 replication cycle and its interactions with the immune system. Most of them are linked to HIV [14], hepatitis virus [15], Ebola [16], influenza [9, 17], and other models.

At present, clinically there is no effective treatment developed to remove the virus from the human body. However, the research is going on. Researchers provided many treatments (like plasma therapy, monoclonal antibody therapy, etc.) which are effective for early diseases like SARS-CoV, MERS-CoV, Ebola, Influenza, HIV-like virus disease. Also we all know that our body immune system gives a good response to fight any viruses or diseases [2].

At the time of SARS-CoV-2 infection, macrophages are first targeted by SARS-CoV-2 and after that these SARS-CoV-2 propagate to T cells. At this stage of the virus route, the T cells activate and further they involve differentiation. Besides, the T cells produce cytokines (INF-α, IL-6, and IL-10) associated with the different types of a T cell. A large amount of cytokines provides a greater activation of the immune response to fight the virus. Particularly T cells, CD4+ T cells, and CD8+ T cells have played a significant antiviral role in a fight against pathogens. There is also a risk of mounting autoimmunity or devastating inflammation. CD4+ T cells help the immune system of the body by generating virus-specific antibodies with the activation of T-dependent B cells. However, CD8+ T cells can kill virally infected cells, as they are cytotoxic. In general, a large number of CD8+ T cells in the infected SARS-CoV-2 body are found in nearly 80% of the total infiltrative inflammatory cells in the interstitial pulmonary tract, which play a significant role in clearing CoVs. The loss of CD4+ T cells is correlated with reduced conscription of lymphocytes and neutralizing the production of antibodies and cytokines, resulting in severe immune-mediated interstitial pneumonitis and delayed SARS-CoV lung clearance [2, 18].

Researchers have shown that there is a long-lasting and persistent response of T cells to the S and other structural proteins (including the proteins M and N), which provides sufficient knowledge to draft SARS vaccine by combining viral structural proteins. These types of vaccine may provide a strong, efficient, and long-term response to the virus by memory cells [3]. Also, clinical trials show that a monoclonal antibody therapy is an effective treatment tool which responds better to SARS-CoV-2 [10]. In our paper, we studied a model of in-host viral kinetics, that describes the response of SARS-CoV-2 to epithelial cells. In Sect. 2, we describe a previously proposed model by Li et al. [5]. We have shown in Sect. 3 that the solutions of the model are biologically feasible. The basic reproduction number is computed and steady state analysis is done in Sect. 4. Sections 5 and 6 deal with the local and global stability of the model, respectively. In Sect. 7, we fitted our theoretical results with MATLAB. A concluding discussion is presented in Sect. 8.

The SARS-CoV-2 infection model

To study the within-host dynamics of SARS-CoV-2 infection, we consider the mathematical model used by Li et al. [5], which is represented by the following ordinary differential equations system:

$$ \begin{aligned} &\frac{dE_{p}(t)}{dt}=d_{E} \bigl(E_{p}(0)-E_{p}(t)\bigr)-\beta E_{p}(t)v(t), \\ &\frac{dE^{*}_{p}(t)}{dt}=\beta E_{p}(t)v(t)-d_{E^{*}}E_{p}^{*}(t), \\ &\frac{dv(t)}{dt}=\pi _{v}E_{p}^{*}(t)-d_{v}v(t). \end{aligned} $$

with the initial conditions as below:

$$ E_{p}(0)>0,\qquad E_{p}^{*}(0)\geq 0\quad \text{and}\quad v(0)\geq 0. $$

Here, the model consists of three population compartments: virus-free pulmonary epithelial cells denoted by \(E_{p}(t)\), virus infected pulmonary epithelial cells denoted by \(E^{*}_{p}(t)\), and the free virus denoted by \(v(t)\). Also, \(d_{E}, d_{E^{*}}\), and \(d_{v}\) represent the death rates of virus-free epithelial cells, virus infected epithelial cells, and the free virus, respectively. Also β denotes the rate at which the virus-free epithelial cells are infected by free virus, \(\pi _{v}\) is the production rate of free virus. In this model, the term \(d_{E}E_{p}(0)\) describes the constant regeneration rate of the virus-free pulmonary epithelial cells.

Basic properties of model (2.1)

Lemma 1

All analytic solutions of model (2.1) with initial conditions (2.2) are nonnegative for all \(t>0\).


We can write the first equation of model (2.1) as

$$ \frac{d}{dt} \biggl[E_{p}(t)\operatorname{exp} \biggl\lbrace \int _{0}^{t} \bigl(\beta v(\mu )+d_{E} \bigr)\,d\mu \biggr\rbrace \biggr]=d_{E}E_{p}(0) \operatorname{exp} \biggl\lbrace \int _{0}^{t} \bigl(\beta v(\mu )+d_{E} \bigr)\,d\mu \biggr\rbrace .$$


$$ E_{p}(t)\operatorname{exp} \biggl\lbrace \int _{0}^{t}\beta v(\mu )\,d\mu +d_{E}t \biggr\rbrace -E_{p}(0)= \int _{0}^{t} \biggl[d_{E}E_{p}(0) \operatorname{exp} \biggl\lbrace \int _{0}^{u}\beta v(\mu )\,d\mu +d_{E}u \biggr\rbrace \biggr]\,du, $$

which implies

$$\begin{aligned} E_{p}(t)={}&\operatorname{exp} \biggl\lbrace - \int _{0}^{t}\beta v(\mu )\,d\mu -d_{E}t \biggr\rbrace \\ &{}\times \biggl[E_{p}(0)+ \int _{0}^{t} \biggl[d_{E}E_{p}(0) \operatorname{exp} \biggl\lbrace \int _{0}^{u}\beta v(\mu )\,d\mu +d_{E}u \biggr\rbrace \biggr]\,du \biggr]. \end{aligned}$$

From the above equation, it is clear that \(E_{p}(t)>0\) for \(t>0\). It can be shown in the same way that \(E_{p}^{*}(t)\geq 0, v(t)\geq 0\) for \(t>0\) [19]. □

Lemma 2

The solutions \(E_{p}(t), E_{p}^{*}(t),v(t)\) of the model (2.1) are bounded for all \(t>0\).


Adding the first two equations of the model (2.1), we get

$$ \frac{d}{dt} \bigl\lbrace E_{p}(t)+E_{p}^{*}(t) \bigr\rbrace =d_{E}\bigl(E_{p}(0)-E_{p}(t) \bigr)-d_{E^{*}}E_{p}^{*}(t) \leq d_{E}E_{p}(0)- \delta \bigl\lbrace E_{p}(t)+E_{p}^{*}(t)\bigr\rbrace , $$

where δ=min\(\lbrace d_{E},d_{E^{*}}\rbrace \). Therefore, the numbers of both the virus-free and infected pulmonary epithelial cells are always bounded. From the third equation of the model, we can easily show that the population of the free virus v is also bounded above. We consider \(K \geq 0\) as the maximum of the above bounds. Therefore, we get the bounded set

$$ \Omega =\biggl\lbrace E_{p}(t),E_{p}^{*}(t),v(t) \in \mathbb{R}^{3}:0\leq E_{p}(t)+E_{p}^{*}(t) \leq \frac{d_{E}E_{p}(0)}{\delta }, v\leq K\biggr\rbrace , $$

where \(K\geq 0\). It is clear that this set is convex. Also using the nonnegativity criteria of solutions of the model (2.1) from Lemma 1 and the boundedness conditions from Lemma 2, it is clear that with the initial conditions \((E_{p}(0), E_{p}^{*}(0), v(0) )\in \Omega \), we have solutions of the model (2.1) again in Ω, i.e., \((E_{p}(t), E_{p}^{*}(t), v(t) )\in \Omega \) for all \(t\geq 0\). Hence, the set Ω is positively invariant w.r.t. the model (2.1). □

Basic reproduction number and steady states

It is straightforward to show that the system has a noninfected steady state \(S_{1}(E_{p}(0),0,0)\). Now, the basic reproduction ratio of the model (2.1) will be calculated with the help of the next generation matrix method. Considering \(Y=(E_{p}^{*}(t),v(t),E_{p}(t))\), we can write the system (2.1) as

$$ \frac{dY}{dt}=A(Y)-T(Y). $$

Here \(A(Y)\) stands for the rate of new infections, \(T(Y)\) stands for the transfer rate of individuals; they are given by

$$ A(Y)= \begin{pmatrix} \beta E_{p}(t)v(t) \\ 0 \\ 0 \end{pmatrix} \quad\text{and}\quad T(Y)= \begin{pmatrix} d_{E^{*}}E_{p}^{*}(t) \\ d_{v}v(t)-\pi _{v}E_{p}^{*}(t) \\ \beta E_{p}(t)v(t)-d_{E}(E_{p}(0)-E_{p}(t)) \end{pmatrix} . $$

The jacobian matrices \(DA(E_{p}(0))\) and \(DT(E_{p}(0))\) at the noninfected steady state are

$$ DA\bigl(E_{p}(0)\bigr)= \begin{pmatrix} a_{2 \times 2} & 0_{2\times 1} \\ 0_{1\times 2} & 0 \end{pmatrix} ,\qquad DT\bigl(E_{p}(0)\bigr)= \begin{pmatrix} t_{2 \times 2}& & 0_{2\times 1} \\ 0 & \beta E_{p}(0) & d_{E} \end{pmatrix}, $$


$$ a_{2\times 2}= \begin{pmatrix} 0 & \beta E_{p}(0) \\ 0 & 0 \end{pmatrix} ,\qquad t_{2 \times 2}= \begin{pmatrix} d_{E^{*}} & 0 \\ -\pi _{v} & d_{v} \end{pmatrix} . $$


$$ at^{-1}=\frac{1}{d_{E^{*}}d_{v}} \begin{pmatrix} \pi _{v}\beta E_{p}(0) & d_{E^{*}}\beta E_{p}(0) \\ 0 & 0 \end{pmatrix} . $$

Therefore, the basic reproduction number \((\chi _{0})\) of the system (2.1) is given by the spectral radius of the matrix \(at^{-1}\) and hence \(\chi _{0}=\frac{\pi _{v}\beta E_{p}(0)}{d_{E^{*}}d_{v}}\).

Also, from a simple calculation it is clear that the model (2.1) has a unique infected steady state

$$ S_{2}=\bigl(\bar{E_{p}},\bar{E_{p}^{*}}, \bar{v}\bigr) \quad\text{whenever } \chi _{0}>1, $$


$$\begin{aligned} &\bar{E_{p}}=\frac{d_{E^{*}}d_{v}}{\beta \pi _{v}}=E_{p}(0) \frac{1}{\chi _{0}}, \\ &\bar{E_{p}^{*}}=\frac{d_{v}\bar{v}}{\pi _{v}}= \frac{d_{v}d_{E}}{\beta \pi _{v}}( \chi _{0}-1), \\ &\bar{v}=\frac{d_{E}}{\beta }(\chi _{0}-1). \end{aligned}$$

Local stability

In this section, we study the local stability behaviors at the different steady states of the model.

Theorem 1

If \(\chi _{0}<1\), then the noninfected steady state \(S_{1}\) is locally asymptotically stable in Ω while for \(\chi _{0}>1\) it becomes unstable.


For the noninfected steady state \(S_{1}\), the Jacobian matrix \(J(S_{1})\) is given by

$$ J(S_{1})= \begin{pmatrix} -d_{E} & 0 & -\beta E_{p}(0) \\ 0 & -d_{E^{*}} & \beta E_{p}(0) \\ 0 & \pi _{v} & -d_{v} \end{pmatrix} .$$

The characteristic equation of the matrix \(J(S_{1})\) is

$$ \lambda ^{3}+a_{1}\lambda ^{2}+a_{2} \lambda +a_{3}=0, $$


$$\begin{aligned} &a_{1}= d_{E}+d_{E^{*}}+d_{v}, \\ &a_{2}= d_{E}(D_{E^{*}}+d_{v})+d_{E^{*}}d_{v}(1- \chi _{0}), \\ &a_{3}= d_{E}d_{E^{*}}d_{v}(1-\chi _{0}), \\ &a_{1}a_{2}-a_{3}=d_{E}^{2}(d_{E^{*}}+d_{v})+d_{E}(d_{E^{*}}+d_{v})^{2}+d_{E^{*}}d_{v}(d_{E^{*}}+d_{v}) (1- \chi _{0}). \end{aligned}$$

Therefore, if \(\chi _{0}<1\), then all the conditions of the Routh–Hurwitz criterion are satisfied. Hence, the noninfected steady state \(S_{1}\) becomes locally asymptotically stable if \(\chi _{0}<1\) and unstable if \(\chi _{0}>1\). □

Theorem 2

The virus-infected steady state \(S_{2}\) is locally asymptotically stable whenever \(\chi _{0}>1\).


For the infected steady state \(S_{2}\), the Jacobian matrix \(J(S_{2})\) is given by

$$ J(S_{2})= \begin{pmatrix} -d_{E}-\beta \bar{v} & 0 & -\beta E_{p} \\ \beta \bar{v} & -d_{E^{*}} & \beta E_{p} \\ 0 & \pi _{v} & -d_{v} \end{pmatrix} .$$

The characteristic equation of the above matrix becomes

$$ \lambda ^{3}+b_{1}\lambda ^{2}+b_{2} \lambda +b_{3}=0, $$


$$\begin{aligned} &b_{1}=d_{E}+\beta \bar{v}+d_{E^{*}}+d_{v}, \\ &b_{2}=(d_{E}+\beta \bar{v}) (d_{E^{*}}+d_{v}), \\ &b_{3}=\beta \bar{v}d_{E^{*}}d_{v}, \\ &b_{1}b_{2}-b_{3}=(d_{E}+\beta \bar{v}+d_{E^{*}}) (d_{E}+\beta \bar{v}) (d_{E^{*}}+d_{v})+d_{v}d_{E}(d_{E^{*}}+d_{v})+d_{v}^{2} \beta \bar{v}. \end{aligned}$$

Thus, \(b_{1}>0, b_{2}>0, b_{3}>0\), and \(b_{1}b_{2}-b_{3}>0\) whenever \(\chi _{0}>1\). This implies that all conditions of the Routh–Hurwitz criterion are satisfied. Hence, the infected steady state \(S_{2}\) is locally asymptotically stable whenever it exists. □

Global stability

From local stability analysis, the behaviors of the system (2.1) near the steady states are obtained. For the behavior of the system (2.1) far away from the steady states, we have carried out a global stability analysis in this section.

Theorem 3

If \(\chi _{0}\leq 1\), then the noninfected steady state \(S_{1}\) approaches a globally asymptotically stable state in Ω and it becomes unstable if \(\chi _{0}>1\).


Define Lyapunov functional of the model (2.1) as

$$ L=\frac{\pi _{v}}{d_{E^{*}}}E_{p}^{*}+v. $$

Now, we differentiate w.r.t. time to obtain

$$ \frac{dL}{dt}=d_{v}v \biggl( \frac{\pi _{v}\beta E_{p}}{d_{E^{*}}d_{v}}-1 \biggr)\leq d_{v}v (\chi _{0}-1 ). $$

It is clear from (6.2) that when \(\chi _{0}\leq 1\), \(\frac{dL}{dt}\leq 0\). Define S to represent the set of solutions of model (2.1) where \(\frac{dL}{dt}=0\). We have \(\frac{dL}{dt}=0\) when \(v=0\) or \(\chi _{0}=1\) and \(E_{p}\leq E_{p}(0)\). Using Lyapunov–Lasalle theorem [20], we have all curves in Ω approach the set S which is also positively invariant. Again, on the boundary of Ω where \(v=0\), we have \(E_{p}^{*}=0\) and \(\frac{dE_{p}(t)}{dt}=d_{E}(E_{p}(0)-E_{p}(t))\). Hence, \(E_{p}\rightarrow E_{p}(0)\) as \(t\rightarrow \infty \). Therefore, when \(\chi _{0}\leq 1\), all solution curves in the domain Ω go to the virus-free steady state \(S_{1}\) and hence \(S_{1}\) is globally asymptotically stable.

From \(J(S_{1})\), it can be easily seen that for \(\chi _{0}>1\), one root of the characteristic equation will be positive. Hence, the noninfected steady state \(S_{1}\) is unstable when \(\chi _{0}>1\). □

Now, the global behavior of the virus-infected steady state \(S_{2}\) whenever it exists will be studied by applying Li and Muldowney criterion [21]. It is easy to visualize the simple connectedness of the interior of set Ω. Also, for \(\chi _{0}>1\), the system (2.1) has the unique steady state \(S_{2}\) in \(\mathrm{int}(\Omega )\). Theorem 3 verifies that \(H\subset \Omega \) exist where H is an absorbing compact set for model (2.1). Hence, all the assumptions for Li and Muldowney global stability criterion [21] are satisfied, and we have the following theorem.

Theorem 4

The infected steady state \(S_{2}\) is globally asymptotically stable whenever \(R_{0}>1\).


The Jacobian matrix of the model (2.1) is

$$ J= \begin{pmatrix} -d_{E}-\beta v & 0 & -\beta E_{p} \\ \beta v & -d_{E^{*}} & \beta E_{p} \\ 0 & \pi _{v} & -d_{v} \end{pmatrix} .$$

The associated second compound matrix \(J^{[2]}\) [21, 22] is given by

$$ J^{[2]}= \begin{pmatrix} -d_{E}-d_{E^{*}}-\beta v & \beta E_{p} & \beta E_{p} \\ \pi _{v} & -d_{E}-d_{v}-\beta v & 0 \\ 0 & \beta v & -d_{E^{*}}-d_{v} \end{pmatrix} .$$


$$ W= \begin{pmatrix} 1 & 0 & 0 \\ 0 & \frac{E_{p}^{*}}{v} & 0 \\ 0 & 0 & \frac{E_{p}^{*}}{v} \end{pmatrix} , $$

to compute the matrix \(W_{f}\), each entry \(w_{ij}\) of matrix W has to be replaced by its derivative in the direction of f. Then,

$$ W_{f}W^{-1}= \begin{pmatrix} 0 & 0 & 0 \\ 0 & \frac{{E_{p}^{*}}'}{E_{p}^{*}}-\frac{v{'}}{v} & 0 \\ 0 & 0 & \frac{{E_{p}^{*}}'}{E_{p}^{*}}-\frac{v{'}}{v} \end{pmatrix} $$


$$\begin{aligned} B&=W_{f}W^{-1}+WJ^{[2]}W^{-1} \\ &= \begin{pmatrix} -d_{E}-d_{E^{*}}-\beta v & \beta E_{p}\frac{v}{E_{p}^{*}} & \beta E_{p} \frac{v}{E_{p}^{*}} \\ \pi _{v}\frac{E_{p}^{*}}{v} & \frac{{E_{p}^{*}}'}{E_{p}^{*}}- \frac{v{'}}{v}-d_{E}-d_{v}-\beta v & 0 \\ 0 & \beta v & \frac{{E_{p}^{*}}'}{E_{p}^{*}}-\frac{v{'}}{v}-d_{E^{*}}-d_{v} \end{pmatrix} \\ &= \begin{pmatrix} B_{11} & B_{12} \\ B_{21} & B_{22} \end{pmatrix}, \end{aligned}$$

where B 11 =( d E d E βv), B 12 = ( β E p v E p β E p v E p ) , B 21 = ( π v E p v 0 ) , and

$$ B_{22}= \begin{pmatrix} \frac{{E_{p}^{*}}'}{E_{p}^{*}}-\frac{v{'}}{v}-d_{E}-d_{v}-\beta v & 0 \\ \beta v & \frac{{E_{p}^{*}}'}{E_{p}^{*}}-\frac{v{'}}{v}-d_{E^{*}}-d_{v} \end{pmatrix} . $$

Now, define Lozinskii measure as follows:

$$ \mu (B)\leq \operatorname{max}\lbrace g_{1}.g_{2}\rbrace, $$

where \(g_{1}=\mu (B_{11})+|B_{12}|\) and \(g_{2}=|B_{21}|+\mu (B_{22})\). Here, \(|B_{12}|\) and \(|B_{21}|\) are with respect to vector norm.


$$\begin{aligned} &\mu (B_{11})=-d_{E}-d_{E^{*}}-\beta v, \\ &\mu (B_{22})=\max \biggl\lbrace \frac{{E_{p}^{*}}'}{E_{p}^{*}}- \frac{v{'}}{v}-d_{E}-d_{v}-\beta v+\beta v, \frac{{E_{p}^{*}}'}{E_{p}^{*}}-\frac{v{'}}{v}-d_{E^{*}}-d_{v} \biggr\rbrace \\ &\phantom{\mu (B_{22})}=\frac{{E_{p}^{*}}'}{E_{p}^{*}}-\frac{v{'}}{v}-\delta -d_{v} \quad\text{where } \delta =\operatorname{min}\lbrace d_{E}, d_{E^{*}}\rbrace, \\ &\vert B_{12} \vert =\beta E_{p}\frac{v}{E_{p}^{*}}, \quad\text{and}\quad \vert B_{21} \vert = \pi _{v} \frac{E_{p}^{*}}{v}. \end{aligned}$$

Using model equations,

$$ \frac{{E_{p}^{*}}'}{E_{p}^{*}}=\frac{\beta E_{p}v}{E_{p}^{*}}-d_{E^{*}} \quad\text{and}\quad \frac{v{'}}{v}=\frac{\pi _{v}E_{p}^{*}}{v}-d_{v}. $$


$$\begin{aligned} &g_{1}=\frac{{E_{p}^{*}}'}{E_{p}^{*}}-d_{E}-\beta v, \\ &g_{2}=\frac{{E_{p}^{*}}'}{E_{p}^{*}}-\delta. \end{aligned}$$

Therefore, we get

$$ \mu (B)\leq \frac{{E_{p}^{*}}'}{E_{p}^{*}}-\delta $$

for large t. Let \((E_{p}(t), E_{p}^{*}(t), v(t))\) be an arbitrary solution such that \((E_{p}(0), E_{p}^{*}(0), v(0))\in H\) and consider any solution \((E_{p}(t), E_{p}^{*}(t), v(t))\in H\) for all \(t\geq \bar{t}\) where is a sufficiently large time. Then, for \(t > \bar{t}\),

$$ \frac{1}{t} \int _{0}^{t}\mu (B)\,ds \leq \frac{1}{t} \int _{0}^{ \bar{t}}\mu (B)\,ds+\frac{1}{t}\ln \frac{E_{p}^{*}(t)}{E_{p}^{*}(\bar{t})}- \biggl(\frac{t-\bar{t}}{t} \biggr)\delta. $$


$$ \bar{q_{2}}:=\lim_{t\rightarrow \infty }\sup \sup _{x_{0}\in H} \frac{1}{t} \int _{0}^{t}\mu \bigl(B\bigl(x(s,x_{0}) \bigr)\bigr)\,ds< 0. $$


Numerical simulation

This section is devoted to numerical simulations in order to substantiate the analytic results. Using Matlab software, analytic results are fitted with the parameters from biologically feasible range for SARS-CoV-2.

Based on chest radiograph score data, Li et al. [5] have estimated the parameters of the model (2.1) using the Monte Carlo Markov Chain (MCMC) method. Using that parameter set, more specifically, \(E_{p}(0)=22.41, E_{p^{*}}(0)=2.59, v(0)=0.061, \pi _{v}=0.24, \beta =0.55, d_{E}=10^{-3}, d_{E^{*}}=0.11\), and \(d_{v}=5.36\), we have \(\chi _{0}=5.01716>1\). Theorem 4 implies that the infected equilibrium point \(S_{2}(4.467,0.163, 0.007)\) is globally asymptotically stable. Figure 1(a) verifies this analytic result. Also, Fig. 1(b) describes the dynamics the numbers of virus-free epithelial cells, virus infected epithelial cells, and free virus.

Figure 1

Dynamics of the numbers of virus-free epithelial cells, virus-infected epithelial cells, and SARS-CoV-2 virus when \(\chi _{0}>1\)

In order to verify the analytic results of the noninfected steady point \(S_{1}\), we consider lowering the infection rate from β to 0.1β by implementing a drug [5]. Hence with this assumption, considering the other parameters the same as in the above simulation, we get \(\chi _{0}=0.501716<1\). As stated by Theorem 3, the noninfected steady state \(S_{1}(22.41, 0, 0)\) is globally asymptotically stable. This analytic result can be verified by Fig. 2(a). Also, the dynamics of the numbers of virus-free epithelial cells, virus-infected epithelial cells, and virus in this scenario are depicted by Fig. 2(b).

Figure 2

Dynamics of the numbers of virus-free epithelial cells, virus-infected epithelial cells, and SARS-CoV-2 virus when \(\chi _{0}<1\)

In the above simulations, we have considered that infection rate β can be lowered by implementing a drug, which leads to the removal of the virus from the human body. But with greater infection rate and other parameters in such a way that \(\chi >1\), the viral load cannot be controlled and infection persists in the human body. This situation can be handled with a proper treatment strategy, otherwise the number of the virus-free epithelial cells will decrease and those of the virus-infected epithelial cells and the free virus will increase in a patient’s body with time. As a result, the patient’s condition will deteriorate with time, which will lead to extreme conditions like death of the patient.


In this paper, we have considered a basic model for within-host dynamics of SARS-CoV-2 used by Li et al. [5] and mathematically analyzed it. First of all, we have proved that all analytic solutions of model (2.1) are nonnegative and uniformly bounded, conditions which are necessary for a biologically feasible model. For the model, we have found two biologically feasible steady states, noninfected and infected steady states. Local stability of both steady states was discussed. Also, we have found the global stability criteria for both steady states. Biologically, it follows that for the basic reproduction number \(\chi _{0}<1\), infection will be cleared from a human body without any treatment; otherwise we have to implement some treatment in order to reduce and to remove the infection from the body. It is our future work to apply different treatment policies in this model in order to clear the virus from an infected human body. It is also found that if basic reproduction number is greater than one then infection will persist for any amount of viral load in the host’s body.

Availability of data and materials

Not applicable.


  1. 1.

    World Health Organization.

  2. 2.

    Li, G., Fan, Y., Lai, Y., et al.: Coronavirus infections and immune responses. J. Med. Virol. 92(4), 424–432 (2020).

    Article  Google Scholar 

  3. 3.

    Mason, R.J.: Pathogenesis of COVID-19 from a cell biology perspective. Eur. Respir. J. 55(4), 2000607 (2020).

    Article  Google Scholar 

  4. 4.

    Liang, K.: Mathematical model of infection kinetics and its analysis for COVID-19, SARS and MERS. Infect. Genet. Evol. 82, 104306 (2020).

    Article  Google Scholar 

  5. 5.

    Li, C., Xu, J., Liu, J., Zhou, Y.: The within-host viral kinetics of SARS-CoV-2. Math. Biosci. Eng. 17(4), 2853–2861 (2020)

    MathSciNet  Article  Google Scholar 

  6. 6.

    Yang, C.Y., Wang, J.: A mathematical model for the novel coronavirus epidemic in Wuhan. China. Math. Biosci. Eng. 17(3), 2708–2724 (2020).

    MathSciNet  Article  Google Scholar 

  7. 7.

    Harapan, H., Itoh, N., Yufika, A., Winardi, W., Keam, S., Te, H., Megawati, D., Hayati, Z., Wagner, A.L., Mudatsir, M.: Coronavirus disease 2019 (COVID-19): a literature review. J. Infect. Public Health 13, 667–673 (2020).

    Article  Google Scholar 

  8. 8.

    Chen, T., Rui, J., Wang, Q., et al.: A mathematical model for simulating the phase-based transmissibility of a novel coronavirus. Infect. Dis. Poverty 9, 24 (2020).

    Article  Google Scholar 

  9. 9.

    Lee, H.Y., Topham, D.J., Park, S.Y., Hollenbaugh, J., Treanor, J., Mosmann, T.R., Xia, J., Ward, B.M., Miao, H., Holden-Wiltse, J., et al.: Simulation and prediction of the adaptive immune response to influenza a virus infection. J. Virol. 83(14), 7151–7165 (2009)

    Article  Google Scholar 

  10. 10.

    Marovich, M., Mascola, J.R., Cohen, M.S.: Monoclonal antibodies for prevention and treatment of COVID-19. JAMA 324(2), 131–132 (2020).

    Article  Google Scholar 

  11. 11.

    Lai, X.: Study of virus dynamics by mathematical models (2014). Electronic Thesis and Dissertation Repository. 1978.

  12. 12.

    Dai, C., Ma, C., Song, L., Wang, K.: Dynamics of a viral infection model with general contact rate between susceptible cells and virus particles. Discrete Dyn. Nat. Soc. (2014); also available online from.

  13. 13.

    Lina, Q., Zhao, S., Gao, D., Lou, Y., Yang, S., Musa, S.S., et al.: A conceptual model for the coronavirus disease 2019 (COVID-19) outbreak in Wuhan, China with individual reaction and governmental action. Int. J. Infect. Dis. 93, 211–216 (2020)

    Article  Google Scholar 

  14. 14.

    Conway, J.M., Ribeiro, R.M.: Modeling the immune response to HIV infection. Curr. Opin. Syst. Biol. 12, 61–69 (2018).

    Article  Google Scholar 

  15. 15.

    Manda, E.C., Chirove, F.: Acute hepatitis B virus infection model within the host incorporating immune cells and cytokine responses. Theory Biosci. 139, 153–169 (2020).

    Article  Google Scholar 

  16. 16.

    Chertow, D.S., Shekhtman, L., Lurie, Y., Davey, R.T., Heller, T., Dahari, H.: Modeling challenges of Ebola virus–host dynamics during infection and treatment. Viruses 12(1), 106 (2020)

    Article  Google Scholar 

  17. 17.

    Cao, P., McCaw, J.M.: The mechanisms for within-host influenza virus control affect model-based assessment and prediction of antiviral treatment. Viruses 9(8), 197 (2017)

    Article  Google Scholar 

  18. 18.

    Du, S.Q., Yuan, W.: Mathematical modeling of interaction between innate and adaptive immune responses in COVID-19 and implications for viral pathogenesis [published online ahead of print, 2020 May 1]. J. Med. Virol. (2020).

    Article  Google Scholar 

  19. 19.

    Dutta, A., Gupta, P.K.: A mathematical model for transmission dynamics of HIV/AIDS with effect of weak CD4+ T cells. Chin. J. Phys. 56(3), 1045–1056 (2018)

    MathSciNet  Article  Google Scholar 

  20. 20.

    LaSalle, J.P.: The stability of dynamical systems. In: Regional Conference Series in Applied Mathematics. SIAM, Philadelphia (1976)

    Google Scholar 

  21. 21.

    Li, M.Y., Muldowney, J.S.: A geometric approach to the global-stability problems. SIAM J. Math. Anal. 27, 1070–1083 (1996)

    MathSciNet  Article  Google Scholar 

  22. 22.

    Wang, L., Li, M.Y.: Mathematical analysis of the global dynamics of a model for HIV infection of cells. Math. Biosci. 200, 44–57 (2006)

    MathSciNet  Article  Google Scholar 

Download references


We would like to thank all the coauthors and the corresponding author Dr. Yu-Ming Chu for arranging funding supported by the National Natural Science Foundation of China (Grant Nos. 11971142, 11871202, 61673169, 11701176, 11626101, 11601485).


The research was supported by the National Natural Science Foundation of China (Grant Nos. 11971142, 11871202, 61673169, 11701176, 11626101, 11601485).

Author information




BJN and KD found the idea of the work; BJN did mathematical part and KD did numerical simulation part; VNM studied the manuscript and suggested some corrections; YMC also suggested some ideas and arranged the funding; HKS went through the final manuscript and gave some of the conclusive ideas. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Yu-Ming Chu.

Ethics declarations

Competing interests

The authors declare that they have no competing interests.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Nath, B.J., Dehingia, K., Mishra, V.N. et al. Mathematical analysis of a within-host model of SARS-CoV-2. Adv Differ Equ 2021, 113 (2021).

Download citation


  • 37N25
  • 34A34
  • 92B05


  • SARS-CoV-2
  • Epithelial cells
  • Global stability
  • Basic reproduction number